IBDEI1NF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29297,0)
 ;;=425.4^^175^1875^17
 ;;^UTILITY(U,$J,358.3,29297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29297,1,3,0)
 ;;=3^Primary Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,29297,1,4,0)
 ;;=4^425.4
 ;;^UTILITY(U,$J,358.3,29297,2)
 ;;=^87808
 ;;^UTILITY(U,$J,358.3,29298,0)
 ;;=428.0^^175^1875^7
 ;;^UTILITY(U,$J,358.3,29298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29298,1,3,0)
 ;;=3^Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,29298,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,29298,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,29299,0)
 ;;=496.^^175^1875^5
 ;;^UTILITY(U,$J,358.3,29299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29299,1,3,0)
 ;;=3^Chr Airway Obstruct Nec
 ;;^UTILITY(U,$J,358.3,29299,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,29299,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,29300,0)
 ;;=491.21^^175^1875^13
 ;;^UTILITY(U,$J,358.3,29300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29300,1,3,0)
 ;;=3^Ob Ch Bronchitis W Exacerb
 ;;^UTILITY(U,$J,358.3,29300,1,4,0)
 ;;=4^491.21
 ;;^UTILITY(U,$J,358.3,29300,2)
 ;;=^269954
 ;;^UTILITY(U,$J,358.3,29301,0)
 ;;=493.20^^175^1875^6
 ;;^UTILITY(U,$J,358.3,29301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29301,1,3,0)
 ;;=3^Chr Obs Asthma W/O Stat Asth/A
 ;;^UTILITY(U,$J,358.3,29301,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,29301,2)
 ;;=^269964
 ;;^UTILITY(U,$J,358.3,29302,0)
 ;;=491.20^^175^1875^14
 ;;^UTILITY(U,$J,358.3,29302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29302,1,3,0)
 ;;=3^Ob Ch Bronchitis W/O Exacerb
 ;;^UTILITY(U,$J,358.3,29302,1,4,0)
 ;;=4^491.20
 ;;^UTILITY(U,$J,358.3,29302,2)
 ;;=^269953
 ;;^UTILITY(U,$J,358.3,29303,0)
 ;;=492.8^^175^1875^10
 ;;^UTILITY(U,$J,358.3,29303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29303,1,3,0)
 ;;=3^Emphysema Nec
 ;;^UTILITY(U,$J,358.3,29303,1,4,0)
 ;;=4^492.8
 ;;^UTILITY(U,$J,358.3,29303,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,29304,0)
 ;;=V17.3^^175^1875^12
 ;;^UTILITY(U,$J,358.3,29304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29304,1,3,0)
 ;;=3^Fam Hx-Ischem Heart Dis
 ;;^UTILITY(U,$J,358.3,29304,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,29304,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,29305,0)
 ;;=410.92^^175^1875^1
 ;;^UTILITY(U,$J,358.3,29305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29305,1,3,0)
 ;;=3^AMI NOS, Subsequent
 ;;^UTILITY(U,$J,358.3,29305,1,4,0)
 ;;=4^410.92
 ;;^UTILITY(U,$J,358.3,29305,2)
 ;;=^269675
 ;;^UTILITY(U,$J,358.3,29306,0)
 ;;=412.^^175^1875^15
 ;;^UTILITY(U,$J,358.3,29306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29306,1,3,0)
 ;;=3^Old Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,29306,1,4,0)
 ;;=4^412.
 ;;^UTILITY(U,$J,358.3,29306,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,29307,0)
 ;;=V45.01^^175^1875^4
 ;;^UTILITY(U,$J,358.3,29307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29307,1,3,0)
 ;;=3^Cardiac Pacemaker In Situ
 ;;^UTILITY(U,$J,358.3,29307,1,4,0)
 ;;=4^V45.01
 ;;^UTILITY(U,$J,358.3,29307,2)
 ;;=^303419
 ;;^UTILITY(U,$J,358.3,29308,0)
 ;;=519.9^^175^1875^18
 ;;^UTILITY(U,$J,358.3,29308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29308,1,3,0)
 ;;=3^Resp System Disease Nos
 ;;^UTILITY(U,$J,358.3,29308,1,4,0)
 ;;=4^519.9
 ;;^UTILITY(U,$J,358.3,29308,2)
 ;;=^105137
 ;;^UTILITY(U,$J,358.3,29309,0)
 ;;=V17.49^^175^1875^11
 ;;^UTILITY(U,$J,358.3,29309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29309,1,3,0)
 ;;=3^Fam Hx-Cardiovas Dis Nec
 ;;^UTILITY(U,$J,358.3,29309,1,4,0)
 ;;=4^V17.49
 ;;^UTILITY(U,$J,358.3,29309,2)
 ;;=^295306
 ;;^UTILITY(U,$J,358.3,29310,0)
 ;;=V45.82^^175^1875^16
 ;;^UTILITY(U,$J,358.3,29310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29310,1,3,0)
 ;;=3^PTCA Status
 ;;
 ;;$END ROU IBDEI1NF
